I'm going to assume that since there are less than a hundred of us at Sierra Oncology, we have nothing to worry about from GlaxoSmithKline? I know this is not their first acquisition by far, so it would be good to know how it went with other companies? I'm not too worried but it's always better to ask than wonder.
There are no replies in this thread yet. Be the first to post a reply below: